Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Sales | 1,640,551 | 1,457,722 | 1,223,198 | 1,160,676 | 811,524 |
| Cost of Goods | 820,794 | 624,651 | 571,882 | 512,209 | 371,781 |
| Gross Profit | 819,757 | 833,071 | 651,316 | 648,467 | 439,743 |
| Operating Expenses | 554,611 | 494,809 | 382,834 | 547,357 | 409,942 |
| Operating Income | 265,940 | 338,913 | 269,364 | 101,319 | 30,582 |
| Interest Expense | 13,330 | 25,808 | 22,081 | 27,812 | 24,284 |
| Other Income | -17,047 | 4,222 | 31,807 | 125,445 | 349,104 |
| Pre-tax Income | 235,563 | 317,327 | 279,090 | 198,952 | 355,402 |
| Income Tax | 85,545 | 115,248 | 103,294 | 82,591 | 184,678 |
| Net Income Continuous | 150,018 | 202,079 | 175,796 | 116,361 | 170,724 |
| Net Income Extraordinary | N/A | N/A | N/A | N/A | -1,216 |
| Net Income | $150,018 | $202,079 | $175,796 | $116,361 | $157,495 |
| EPS Basic Total Ops | 1.37 | 1.88 | 1.65 | 1.10 | 1.55 |
| EPS Basic Continuous Ops | 1.37 | 1.88 | 1.65 | 1.10 | 1.68 |
| EPS Diluted Total Ops | 1.26 | 1.74 | 1.64 | 1.07 | 1.52 |
| EPS Diluted Continuous Ops | 1.20 | 1.67 | 1.64 | 1.07 | 1.65 |
| EBITDA(a) | $372,606 | $439,265 | $355,940 | $202,544 | $101,991 |